These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacological management of common urodynamic problems. Milroy E. Urol Clin North Am; 1979 Feb; 6(1):265-72. PubMed ID: 34915 [No Abstract] [Full Text] [Related]
3. Pharmacological treatment of lower urinary tract dysfunction. Raz S. Urol Clin North Am; 1978 Jun; 5(2):323-24. PubMed ID: 28599 [No Abstract] [Full Text] [Related]
4. [Evaluation and treatment of neurogenic vesico-sphincter dysfunction]. Amarenco G. Ann Urol (Paris); 1993 Jun; 27(6-7):313-20. PubMed ID: 8297160 [Abstract] [Full Text] [Related]
5. [Pharmacological treatment of urinary incontinence and difficulty in emptying the bladder in women]. Thind P, Lose G. Ugeskr Laeger; 1985 Dec 02; 147(49):3989-92. PubMed ID: 2868553 [No Abstract] [Full Text] [Related]
6. Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. Jung SY, Fraser MO, Ozawa H, Yokoyama O, Yoshiyama M, De Groat WC, Chancellor MB. J Urol; 1999 Jul 02; 162(1):204-12. PubMed ID: 10379788 [Abstract] [Full Text] [Related]
7. [Pharmacologic treatment of urinary dysfunctions]. Jurascheck F. Ann Urol (Paris); 1993 Jul 02; 27(6-7):331-9. PubMed ID: 8297164 [Abstract] [Full Text] [Related]
8. Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure. Yokoyama O, Miwa Y, Oyama N, Aoki Y, Ito H, Akino H. J Urol; 2007 Nov 02; 178(5):2208-12. PubMed ID: 17870108 [Abstract] [Full Text] [Related]
10. Pharmacologic treatment of disorders of bladder and urethra: a review. Awad SA, Downie JW, Kiruluta HG. Can J Surg; 1979 Nov 02; 22(6):515-8. PubMed ID: 40680 [Abstract] [Full Text] [Related]
11. Medication: its role in the cause and treatment of urinary incontinence. DeRidder PA, Vallerand HG. J Enterostomal Ther; 1986 Nov 02; 13(5):187-9. PubMed ID: 2876016 [No Abstract] [Full Text] [Related]
12. [Effect of anticholinergics on bladder tonus and on the voiding function]. Kelly LU, Wehnert J. Z Urol Nephrol; 1979 Oct 02; 72(10):765-9. PubMed ID: 532394 [Abstract] [Full Text] [Related]
13. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder. Goldenberg MM. Clin Ther; 1999 Apr 02; 21(4):634-42. PubMed ID: 10363730 [Abstract] [Full Text] [Related]
14. [Effect of Mictonorm (propiverin hydrochloride) on the female urethra]. Höfner K, Dorschner W, Höfner T, Dieterich F. Zentralbl Gynakol; 1986 Apr 02; 108(18):1124-9. PubMed ID: 3788341 [Abstract] [Full Text] [Related]
15. Drug treatment of the overactive detrusor. Andersson KE, Ulmsten U. Acta Pharmacol Toxicol (Copenh); 1980 Apr 02; 46 Suppl 1():7-11. PubMed ID: 6104413 [No Abstract] [Full Text] [Related]
16. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Smith CP, Nishiguchi J, O'Leary M, Yoshimura N, Chancellor MB. Urology; 2005 Jan 02; 65(1):37-41. PubMed ID: 15667859 [Abstract] [Full Text] [Related]
19. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Kuo HC. Urology; 2004 May 02; 63(5):868-72. PubMed ID: 15134967 [Abstract] [Full Text] [Related]
20. [Conservative treatment of functional disorders of the lower urinary tract]. Frohneberg D, Thüroff JW, Müller SC, Petri E. Gynakologe; 1983 Dec 02; 16(4):206-13. PubMed ID: 6363223 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]